Biotech entity
Robert F. Kennedy Jr. is the most frequent co-covered peer, appearing in 2 of the 4 tracked stories. The 140-day window averages about 0.2 stories each week. The busiest single day carried 2. They are better corroborated than the beat average, carrying 10.3 original sources each against 3.8 for the same window.
Last mentioned: Jul 12, 2026
Entity pulse
Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 50 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Robert F. Kennedy Jr. is the most frequent co-covered peer, appearing in 2 of the 4 tracked stories. The 140-day window averages about 0.2 stories each week. The busiest single day carried 2. They are better corroborated than the beat average, carrying 10.3 original sources each against 3.8 for the same window. pharma accounts for 2 of the 4 tracked stories, while 2 other categories carry the remainder. Their average consequence score of 6.8 runs above the beat's 6.4 for that window. U.S. Department of Health and Human Services appears in 4 tracked Biotech stories published from March 17, 2026 through August 3, 2026.
Computed from the 4 stories linked to this entity, with beat comparisons drawn from all 358 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering U.S. Department of Health and Human Services. Shared-story counts are live from our verified record — not editorial picks.
Court Ruling
Judge Brian Murphy issues a stay, halting the implementation of the vaccine overhaul.
Legal Challenge
The AAP and ACP file suit in Massachusetts federal court to block the changes.
ACIP Restructuring
HHS replaces existing ACIP members with figures aligned with the administration's views.
HHS Policy Shift
Secretary RFK Jr. issues a memo reducing universal vaccine recommendations.
HHS announced $281M in mental health and addiction grants, with $68.2M dedicated to medication-assisted treatment (MAT) for opioid use disorder, opening demand opportunities for pharma companies and biotech startups in the addiction space.
Source: hawaiitribune-herald.com · slguardian.org
HHS Secretary Kennedy warns that Chinese companies accounted for nearly half of global pharmaceutical licensing deals in 2025, prompting FDA actions to streamline early-stage trials and potentially reduce drug development times by 6 to 12 months. The shift could reshape US biotech competitiveness and investment returns.
The DOJ’s operation specifically targeted fraudulent genetic testing schemes, sending shockwaves through biotech and pharma reliant on lab services. A new Data Fusion Center and $48.6M in settlements signal aggressive federal interest in precision medicine marketing.
Source: wercfm.iheart.com · knst.iheart.com
A Massachusetts federal judge has blocked the Trump administration's attempts to dismantle the standard U.S. vaccine schedule. The ruling halts Robert F. Kennedy Jr.’s efforts to reduce recommended pediatric immunizations, citing a failure to follow established scientific and procedural laws.
U.S. Department of Health and Human Services is linked from 4 stories on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
